Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

80.35 USD +0.86 (+1.08%)
Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arena Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stocks With Rising Relative Strength: Arena Pharmaceuticals
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript
ARNA earnings call for the period ending December 31, 2020. 
Tags Market News ARNA
From Motley Fool
Recap: Arena Pharmaceuticals Q4 Earnings
Shares of Arena Pharmaceuticals (NASDAQ:ARNA) were flat in after-market trading after the company reported Q4 results. Quarterly ... 
Tags Earnings ARNA Benzinga
From Benzinga
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the Quarter
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020. 
From Business Wire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ESPR CELC MGNX
From Benzinga
Earnings Scheduled For February 23, 2021
Companies Reporting Before The Bell • MFA Finl (NYSE:MFA) is likely to report quarterly earnings at $0.07 per share on ... 
Tags CDEV NXST MASI
From Benzinga
Arena Pharmaceuticals Earnings Preview
On Tuesday, February 23, Arena Pharmaceuticals (NASDAQ:ARNA) will release its latest earnings report. Check out Benzinga's preview ... 
Tags Market News Earnings ARNA
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags ALIM ICPT EDIT
From Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Board of Directors granted to eleven new employees inducement stock options to... 
From Business Wire News Releases
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23. 
From Business Wire News Releases
Arena Pharmaceuticals Announces Changes to Board of Directors
Industry veteran Garry Neil, MD named Board Chair. Nawal Ouzren, CEO of Sensorion named to Board. 
From Business Wire News Releases
Code red — here’s what it means for the stock market now that company insiders are selling shares
The stock market is vulnerable to a decline because of overvaluation, while "reopening" and cyclical stocks have been overplayed. 
Tags MRVL ROAD CRSP
From MarketWatch
Arena Pharmaceuticals Completes Full Enrollment of Etrasimod Phase 3 ELEVATE UC 52 Trial
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it has completed full enrollment of the Phase 3 ELEVATE UC 52 trial evaluating the safety and efficacy of etrasimod, a highly selective,... 
From Business Wire News Releases
Cannabis Stock Gainers And Losers From January 29, 2021
GAINERS: Rhinomed(OTCQB: RHNMF) shares closed up 37.49% at $0.12 Cannabix Technologies(PINK: BLOZF) shares closed up ... 
Tags CANN NEXCF CXXIF
From Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on January 15, 2021, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to... 
From Business Wire News Releases
Arena Pharmaceuticals Larger Than S&P 500 Component HollyFrontier
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Arena Pharmaceuticals Inc (ARNA) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Earns IBD Rating Upgrade
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to present virtually at the 39th Annual J.P. Morgan... 
From PR Newswire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on December 15, 2020, the Compensation Committee of its Board of Directors granted to five new employees inducement stock options to... 
From PR Newswire
First Week of March 2021 Options Trading For Arena Pharmaceuticals (ARNA)
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available this week, for the March 2021 expiration. One of the key data points that goes into the price an option buyer is willing... 
Tags Stocks
From Market News Video
The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics
Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock ... 
Tags PFE RHHBY Benzinga
From Benzinga
Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial - Late-Breaker at Revolutionizing Atopic Dermatitis Conference
- Data selected for late-breaker oral presentation on December 14 
From PR Newswire
Arena Pharmaceuticals Gets Relative Strength Rating Upgrade
Arena Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod Phase 3 ELEVATE UC 52 Trial
- Evaluating 2 mg etrasimod in study participants with moderately to severely active ulcerative colitis (UC) 
From PR Newswire
Arena Pharmaceuticals Announces R&D Leadership Transition
Arena Pharmaceuticals announces the appointment of Paul D. Streck, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer. 
From Business Wire News Releases
Cannabis Central: The Pure-Play Pot Stock Index Moved Up On Monday
The Pure-Play Pot Stock Index went up 1.1% on Monday.14 of the 25 constituents went up, 9 went down and 2 had no change in price. In addition, 2 of the 3 index categories went up as well. 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on December 1
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd... 
From PR Newswire
First Week of July 2021 Options Trading For Arena Pharmaceuticals (ARNA)
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on November 15, 2020, the Compensation Committee of its Board of Directors granted to 13 new employees inducement stock options to... 
From PR Newswire
Benzinga's Top Upgrades, Downgrades For November 19, 2020
Upgrades According to MKM Partners, the prior rating for Target Corp (NYSE: TGT) was changed from Sell to Neutral. Target earned ... 
Tags JPM FCEL C
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.